# A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).

> **NCT00974974** · PHASE3 · COMPLETED · sponsor: **Impax Laboratories, LLC** · enrollment: 471 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** IPX066
- **DRUG:** IR CD-LD

## Key facts

- **NCT ID:** NCT00974974
- **Lead sponsor:** Impax Laboratories, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2011-01
- **Final completion:** 2011-03
- **Target enrollment:** 471 (ACTUAL)
- **Last updated:** 2020-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00974974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00974974, "A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00974974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*